Does L-Theanine Improve Sleep? What Human Trials Show

L-theanine may help some people feel that they sleep better. The best current synthesis of randomized trials found a statistically significant pooled improvement in subjective sleep-related outcomes. That is enough to make L-theanine a reasonable low-stakes experiment for someone seeking a mild improvement in perceived sleep quality. It is not enough to call it a reliable sleep treatment.

The reason is simple: much of the favorable evidence comes from small, short trials of products that combined L-theanine with other ingredients. Studies that come closer to testing L-theanine alone have not consistently shown a placebo-beating improvement in standard subjective or objective sleep measures. The gap between "I slept better" and "the supplement measurably improved sleep" matters.

What the best overall evidence found

A 2025 systematic review and meta-analysis by Bulman et al. reviewed 19 articles and pooled 18 studies involving 897 participants. Its headline result favored L-theanine supplementation for subjective sleep-related outcomes. In other words, across the trial literature, participants who took L-theanine-containing interventions tended to report better sleep-related experiences than comparison groups.

That result deserves attention, but it does not settle the question people usually ask at the supplement shelf: does L-theanine itself improve sleep? The review's authors flagged a major obstacle—too few studies tested pure L-theanine. When a trial uses a multi-ingredient sleep product, any benefit could come from another ingredient, the combination, or L-theanine's contribution to the combination. The trial cannot assign credit cleanly.

A 2026 systematic review by Cotter et al. reached the appropriately cautious field-level view: human trials justify continued interest, but they do not establish a large or clinically meaningful effect on sleep physiology. The recurring signal is more convincing for self-reported sleep than for objective measures such as actigraphy-derived sleep outcomes.

Why subjective improvement still counts—and why it has limits

Sleep is partly an experience. If a person falls asleep feeling calmer, wakes less distressed by a rough night, and reports better sleep quality, that can matter in daily life. A validated questionnaire or sleep diary is not fake data.

But subjective outcomes and objective outcomes answer different questions. A diary can show that someone perceived better sleep; it cannot by itself show a meaningful change in sleep architecture, sleep efficiency, or total sleep time. Supplements often look more favorable on perceived sleep than on measurable sleep. For L-theanine, the current evidence supports the first claim more clearly than the second.

The distinction also guards against inflated expectations. A statistically significant pooled result can be small, and a small change on a sleep scale may not alter daytime function in a way a person notices. The published summary of the 2025 meta-analysis establishes statistical significance for pooled subjective outcomes, but the information available here does not provide a single effect estimate or confidence interval to judge the size and precision of that pooled benefit. That leaves clinical importance unresolved.

Combination trials show possibility, not attribution

A 2022 double-blind, randomized, placebo-controlled crossover trial by Thiagarajah et al. tested alpha-s1-casein tryptic hydrolysate plus L-theanine in people with poor sleep quality. The combination improved Pittsburgh Sleep Quality Index scores, increased total sleep time by about 45 minutes, and improved habitual sleep efficiency and daytime dysfunction. The crossover design strengthens within-person comparisons because participants can be compared with themselves under different conditions.

Still, this was a test of a combination, not L-theanine alone. The result shows that the product improved several reported sleep outcomes under the study conditions. It cannot show whether L-theanine drove the effect, whether the casein-derived ingredient did, or whether both were necessary.

Other combination trials supply a useful corrective. In a 2024 randomized, placebo-controlled trial by Gutiérrez-Romero et al., a bedtime nutraceutical combination containing 200 mg of L-theanine plus botanicals produced no significant between-group benefit on actigraphy, PSQI, SF-36, or cortisol in people with impaired sleep. The null results covered both a subjective sleep questionnaire and objective actigraphy, which makes this more than a technical disappointment.

Likewise, a 2024 double-blind, randomized, placebo-controlled study by Lim et al. tested Lactium plus L-theanine in adults with sleep disturbance. The trial found modest within-group improvements in sleep-diary measures, but no significant between-group effects on PSQI or the Insomnia Severity Index. Within-group change can reflect many things, including time, expectation, and regression toward average symptoms. The placebo comparison is the result that best tests whether the intervention added something beyond those influences.

The pure-L-theanine trial is the tougher test

The most direct evidence comes from a 2024 randomized, double-blind, placebo-controlled trial by Moulin et al.. Healthy adults with moderate stress took 400 mg per day of AlphaWave L-theanine or placebo for 28 days. The study found no significant between-group differences in subjective sleep data and mixed findings on actigraphy.

This trial does not prove that L-theanine never helps sleep. Its population consisted of healthy adults with moderate stress, not people selected for insomnia or poor sleep quality, and its follow-up lasted four weeks. But it directly limits broad claims that L-theanine reliably improves sleep on its own. When the standalone question gets a standalone test, the answer so far is uncertain.

Why the studies do not line up neatly

The studies differ in more than their results. They tested different populations, formulations, comparators, durations, and endpoints. Some enrolled poor sleepers or adults with sleep disturbance; the pure-L-theanine study enrolled healthy adults with moderate stress. Some examined mixtures that may have produced effects L-theanine alone would not. Others measured diaries and questionnaires, while some included actigraphy. Those differences can produce real differences in results, especially in a small literature.

The evidence base also has practical limits: trials are generally short, participant groups are mixed, and the number of pure-L-theanine studies remains thin. That makes it hard to know whether a benefit persists, who is most likely to notice it, or whether it matters enough to change clinical care. Larger, longer placebo-controlled trials of pure L-theanine in clearly defined poor sleepers or people with insomnia should measure both validated patient-reported outcomes and objective sleep endpoints.

Verdict: reasonable curiosity, restrained expectations

L-theanine has a real but modest evidence signal for perceived sleep improvement. The 2025 meta-analysis means the idea is not simply marketing wearing a green-tea costume. Yet the strongest conclusion still stops short of "L-theanine improves sleep" in the broad, objective, standalone sense people often mean.

If you want a mild experiment for perceived sleep quality, the human evidence supports trying it with modest expectations. If you have persistent insomnia, major daytime impairment, loud snoring, breathing pauses, or escalating reliance on sleep aids, treat that as a medical problem worth evaluating rather than a supplement-selection puzzle. L-theanine has not yet earned the status of a reliably effective sleep intervention with clear causal proof and consistent objective benefits.